Search
Search Results
##search.searchResults.foundPlural##
-
Magnusiomyces capitatus Breakthrough Infection in Allogeneic Hematopoietic Cell Transplant Recipients Receiving Echinocandin Prophylaxis: Clinical Features, Management, and Review of the Literature
97PDF: 161Suppl. Files: 20Html: 106Html Suppl. Files: 80 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4930PDF: 1622HTML: 2273Untitled: 273Untitled: 291Untitled: 310Untitled: 259Untitled: 274 -
WHAT ARE FUNGAL INFECTIONS?
4394PDF: 2504HTML: 27707de Pauw: 287 -
UPDATE ON THE LABORATORY DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS
2548PDF: 1507HTML: 2028 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1929PDF: 798HTML: 568 -
FUNGAL INFECTIONS OF THE EAR IN IMMUNOCOMPROMISED HOST: A REVIEW
3914PDF: 1616HTML: 3895Letter to Editor: 233 -
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
2445PDF: 1020HTML: 11172 -
-
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2166PDF: 1111HTML: 15743COVER LETTER: 237 -
EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
2350PDF: 1054HTML: 4989 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
3018PDF: 1034HTML: 7516 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1553PDF: 1399HTML: 121 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4450PDF: 1452HTML: 2203 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3597PDF: 1458HTML: 2729 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3373PDF: 1940HTML: 3711 -
As a Rare Site of Invasive Fungal Infection, Chronic Granulomatous Aspergillus Synovitis: A Case Report
1812PDF: 671HTML: 1560Figure 1: MRI demonstrating Aspergillus synovitis: 224Figure 2:MRI demonstrating Aspergillus synovitis: 233 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2922PDF: 977HTML: 308 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4979PDF: 1881HTML: 2879Untitled: 286 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
2212PDF: 1174HTML: 10764Untitled: 238 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2426PDF: 793HTML: 2155Untitled: 270Untitled: 192Untitled: 226Untitled: 202Untitled: 216Untitled: 237Untitled: 229 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1300PDF: 581HTML: 1716Figures: 208Fifures Sanz: 219tables Sanz: 222Untitled: 218 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4205PDF: 1321HTML: 2126Table 1: 233 -
Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
2063PDF: 1183HTML: 1936Lung computed tomography CT scan image: 237 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3955PDF: 1371HTML: 967Figure 2: 507Figure 1: 3194 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4521PDF: 986HTML: 1367Table1: 241 -
TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY Stepdown Therapy of Candidemia
2335PDF: 778HTML: 361 -
EFFECT OF FRESH VERSUS CRYOPRESERVED GRAFTS ON FEBRILE NEUTROPENIA AND INFECTIONS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: FACTORS DETERMINING MORTALITY. Fresh vs Frozen Grafts: Infection and Outcome
1082PDF: 838HTML: 323 -
The diagnostic pitfalls of mucormycosis
1045PDF: 767HTML: 299 -
TOO MANY MOULDY JOINTS – MARIJUANA AND CHRONIC PULMONARY ASPERGILLOSIS
3330PDF: 1484HTML: 14012jdoe, Dening.MarijuanaFi7.doc: 241jdoe, Dening.MarijuanaFi6.doc: 225jdoe, Dening.MarijuanaFi5.doc: 218jdoe, Dening.MarijuanaFi4.doc: 231jdoe, Dening.MarijuanaFi3.doc: 241jdoe, Dening.MarijuanaFi2.doc: 290jdoe, Dening.MarijuanaFig1.doc: 258







